Trial intelligence / Profile preview

Verapamil versus nicardipine for prevention of radial artery conduit spasm during CABG

NL-OMON38886Active, not recruiting

Sponsor
Catharina Ziekenhuis
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of verapamil and nicardipine in coronary arteriosclerosis and radial artery spasm (2 arms), sponsored by Catharina Ziekenhuis. Primary endpoint: Mean free flow through the radial artery conduit. Started Oct 2013; status: active, not recruiting.

02

Drugs

verapamilnicardipine
03

Conditions

coronary arteriosclerosisradial artery spasm

Beyond the preview

Go deeper on NL-OMON38886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call